❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Eivind Hovig's group ❭ Eivinds work calendar ❭

Eivinds work calendar

Scroll to top

Home Dept. of Tumor Biology Eivind Hovig's group

  • Eivinds work calendar
  • Total staff list
  • Wet-lab group
  • DNR Bioinformatics
  • Research interests
    • Mutation analysis
    • Gene therapy
    • DNA variation
    • Links
  • Publications
  • Company affiliations
  • Press (mostly in Norw.)
  • Inherited and Familial Cancer [Dominguez-Valentin]
  • Genomic Regulation for Precision Cancer Medicine Lab [Urbanucci]
  • Autophagy in cancer [Engedal]
  • DNA analysis and methods [Ekstrøm]

Recent publications

Krossa S, Andersen MK, Sandholm EM, Wess M, Kiviaho A, Sharma A, Hakkola S, Hao Y, Alshalalfa M, Davicioni E, Viset T, Størkersen Ø, Karnes RJ, Spratt DE, Giskeødegård GF, Nykter M, Rye MB, Urbanucci A, Tessem MB (2025)
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment
Nat Commun, 16 (1), 10160
DOI 10.1038/s41467-025-65161-9, PubMed 41258098

Lamsal A, Andersen SB, Nonstad U, Kurganovs NJ, Skipworth RJ, Bjørkøy G, Pettersen K (2025)
Correction: A role of arginase-1-expressing myeloid cells in cachexia
Cancer Metab, 13 (1), 44
DOI 10.1186/s40170-025-00412-3, PubMed 41204350

Lallier M, Robeyns R, Mertens F, Sisto A, De Meyer GRY, Augustyns K, Berg M, De Vos WH, Timmerman V, Janssen GMC, van Veelen P, van Nuijs ALN, Engedal N, Martinet W, Van der Veken P (2025)
Biarylacetamides: a novel class of late-stage autophagy inhibitors
Autophagy Rep, 4 (1), 2541597
DOI 10.1080/27694127.2025.2541597, PubMed 40964235



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)